These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2533148

  • 1. A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
    Stevenson JC, Lees B, Gardner R, Shaw RW.
    Horm Res; 1989; 32 Suppl 1():161-3; discussion 164. PubMed ID: 2533148
    [Abstract] [Full Text] [Related]

  • 2. Goserelin versus danazol in the treatment of endometriosis.
    Giorgino FL, Cetera C, de Laurentiis G.
    Clin Exp Obstet Gynecol; 1991; 18(2):127-31. PubMed ID: 1833094
    [Abstract] [Full Text] [Related]

  • 3. Bone mass in endometriosis patients treated with GnRH agonist implant or danazol.
    Dodin S, Lemay A, Maheux R, Dumont M, Turcot-Lemay L.
    Obstet Gynecol; 1991 Mar; 77(3):410-5. PubMed ID: 1825135
    [Abstract] [Full Text] [Related]

  • 4. Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.
    Crook D, Gardner R, Worthington M, Nolan J, Stevenson JC, Shaw RW.
    Horm Res; 1989 Mar; 32 Suppl 1():157-60. PubMed ID: 2533147
    [Abstract] [Full Text] [Related]

  • 5. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team.
    Shaw RW.
    Fertil Steril; 1992 Aug; 58(2):265-72. PubMed ID: 1386029
    [Abstract] [Full Text] [Related]

  • 6. A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience.
    Yee B.
    Prog Clin Biol Res; 1986 Aug; 225():175-88. PubMed ID: 3097664
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group.
    Dawood MY, Spellacy WN, Dmowski WP, Gambrell RD, Greenblatt RB, Girard Y, Lemay A, Mishell DR, Nagamani M, Pepperell RJ.
    Prog Clin Biol Res; 1990 Aug; 323():253-67. PubMed ID: 2106142
    [No Abstract] [Full Text] [Related]

  • 8. Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis.
    Golland IM, Vaughan-Williams CA, Shalet SM, Laing I, Elstein M.
    Acta Endocrinol (Copenh); 1990 Oct; 123(4):405-10. PubMed ID: 2146853
    [Abstract] [Full Text] [Related]

  • 9. The effect of LHRH agonist therapy in the treatment of endometriosis (English experience).
    Jelley RY, Magill PJ.
    Prog Clin Biol Res; 1986 Oct; 225():227-38. PubMed ID: 3097668
    [Abstract] [Full Text] [Related]

  • 10. [Goserelin depot: an analog of LHRH for the treatment of endometriosis].
    Shaw RW.
    Drugs Exp Clin Res; 1990 Oct; 16 Suppl():69-75. PubMed ID: 2150504
    [No Abstract] [Full Text] [Related]

  • 11. Buserelin versus danazol in the treatment of endometriosis-associated infertility.
    Fedele L, Bianchi S, Arcaini L, Vercellini P, Candiani GB.
    Am J Obstet Gynecol; 1989 Oct; 161(4):871-6. PubMed ID: 2529770
    [Abstract] [Full Text] [Related]

  • 12. Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study.
    Dmowski WP, Radwanska E, Binor Z, Tummon I, Pepping P.
    Fertil Steril; 1989 Mar; 51(3):395-400. PubMed ID: 2493400
    [Abstract] [Full Text] [Related]

  • 13. The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
    Maouris P, Dowsett M, Rose G, Edmonds DK, Rothwell C, Robertson WR.
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):539-46. PubMed ID: 2146047
    [Abstract] [Full Text] [Related]

  • 14. Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol.
    Lemay A, Brideau NA, Forest JC, Dodin S, Maheux R.
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):305-10. PubMed ID: 1836425
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of intranasal buserelin acetate in the treatment of endometriosis: a review of six clinical trials and comparison with danazol.
    Trabant H, Widdra W, de Looze S.
    Prog Clin Biol Res; 1990 Oct; 323():357-82. PubMed ID: 2106146
    [Abstract] [Full Text] [Related]

  • 16. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
    Rock JA, Truglia JA, Caplan RJ.
    Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis.
    Dlugi AM, Rufo S, D'Amico JF, Seibel MM.
    Fertil Steril; 1988 May; 49(5):913-6. PubMed ID: 3129319
    [Abstract] [Full Text] [Related]

  • 18. Endometrial patterns during danazol and buserelin therapy for endometriosis: comparative structural and ultrastructural study.
    Fedele L, Marchini M, Bianchi S, Baglioni A, Bocciolone L, Nava S.
    Obstet Gynecol; 1990 Jul; 76(1):79-84. PubMed ID: 2113661
    [Abstract] [Full Text] [Related]

  • 19. Hormone treatment related bone mineral content changes in Japanese women with endometriosis.
    Fukushima M, Shindo M, Sato K.
    Asia Oceania J Obstet Gynaecol; 1993 Sep; 19(3):299-307. PubMed ID: 8250765
    [Abstract] [Full Text] [Related]

  • 20. Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients.
    Franssen AM, Rolland R, Chadha DR, Willemsen WN, Vemer HM.
    Eur J Obstet Gynecol Reprod Biol; 1986 Dec; 23(5-6):379-86. PubMed ID: 3100357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.